Another 52 Week High for Skinvisible

Our client Skinvisible Inc. (OTCQB: SKVI) has had huge news in the past two months. We have covered the Company most of the past four years, and we signed a renewed agreement to handle investor relations on an ongoing basis in the middle of July.

We give all credit to the Company (and not ourselves) as the stock is now up 108% since we started with them again. 

The reason for their success is really several reasons:

  1. The fundamentals of the Company. No preferred shares or anything that would undermine shareholder equity. 
  2. The products are outstanding due to a very unique polymer that is very well protected via a substantial patent portfolio. Read about Invisicare. 
  3. Their DermSafe product is needed right now as pathogens become more and more of an issue. DermSafe is not simply a product you put on to “clean your hands” like some of the typical alcohol based hand cleaners.  DermSafe protects for up to FOUR HOURS AFTER YOU PUT IT ON. That’s right, the polymer binds to your skin with the active ingredient that kills for up to four hours. More on this soon. 
  4. Kintari. There is a lot more to come on Kintari. It’s going to be big. I have a few links below on it. 

 

About Kintari: 

KINTARI_LOGO-350w

Skinvisible Pharmaceuticals $SKVI adds Key People to #Kintari

Skinvisible’s Kintari $SKVI – The Story Behind This New Network Marketing Subsidiary

Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) $SKVI #Kintari

Network Marketing Competitors: Skivisible Pharmaceuticals’ $SKVI new Kintari subsidiary

Skinvisible $SKVI Appoints Rob Barnes as Kintari Director of Sales

Skinvisible $SKVI #Kintari Recently Featured in an article by Andrew McDougall on CosmeticDesign.com, a Leading Industry News Site

Skinvisible $SKVI is Investing in long Term Growth with its Network Marketing Subsidiary Kintari

More About Skinvisible $SKVI and Kintari, The New Network Marketing Subsidiary

 

 

 

 

John Pentony now represents Skinvisible Pharmaceuticals, Inc. as its investor relations coordinator internally. In the past John Pentony’s company was hired for the distribution of news and blogs about Skinvisible. John Pentony and any family member or associated companies do not hold shares, warrants or other positions in Skinvisible stock. In years past John Pentony’s company (Pentony Enterprise LLC / “PE”) has received a total of eight thousand in cash payments. In 2009 PE was compensated 500k shares of restricted stock. John Pentony has signed a contract to as investor relations for Skinvisible, and will be paid up to eleven thousand dollars during the next twelve months should the contract go for twelve months as expected.